HCPCS Level IIdrugActive
J3105
Terbutaline sulfate inj
BETOS: O1E
Effective: 1997-01-01
Referenced in 1 policies
Description
Injection, terbutaline sulfate, up to 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Terbutaline Sulfate
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
1 MG
Billing Units
1.0000
5
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.